Addressing Patients with Pruritus: Counseling & Treatment
PART 2
The well-known Dr. Gil Yosipovitch, Professor of Dermatology at the University of Miami Miller School of Medicine and Director of the Miami Itch Center, recently lectured on various aspects of itch at the 2018 ODAC meeting. He has asked his two research fellows to write on the topic for Next Steps in Dermatology. This is the second article in our 2-part series.
Counseling patien …
PART 2
The well-known Dr. Gil Yosipovitch, Professor of Dermatology at the University of Miami Miller School of Medicine and Director of the Miami Itch Center, recently lectured on various aspects of itch at the 2018 ODAC meeting. He has asked his two research fellows to write on the topic for Next Steps in Dermatology. This is the second article in our 2-part series.
Counseling patien … Continue reading "Addressing Patients with Pruritus: Counseling & Treatment"
PART 1
The well-known Dr. Gil Yosipovitch, Professor of Dermatology at the University of Miami Miller School of Medicine and Director of the Miami Itch Center, recently lectured on various aspects of itch at the 2018 ODAC meeting. He has asked his two research fellows to write on the topic for Next Steps in Dermatology. This is the first article in a 2-part series about itch.
A … 
JDD Dermatology Podcasts present the latest JDD journal content related to advances in drugs, devices and treatment methods in dermatology, in a new convenient audio format. From article abstracts to interviews, JDD Dermatology Podcasts provide a fresh perspective of the peer reviewed content you have come to rely on from JDD (Journal of Drugs in Dermatology).
Hosted by Adam Friedman, … 
Below are the issue highlights and Editor Picks for the March issue of JDD!
Papp and Lebwohl review clinical data on the use of biologics in moderate-to-severe psoriasis, identifying which biologics may offer the quickest results in Onset of Action of Biologics in Patients With Moderate-to-Severe Psoriasis.
In Clinical Insights About Onychomycosis and Its Treatment: A Consensus, au … 
Catch up on your JDD reading with highlights from the August issue, Special Focus: Psoriasis.
Strober, Bagel, and Lebwohl et al present Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study READ NOW
The Static Physician’s Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Ps …